Skip to content
To the full analysis

Angel Yeast Stock: Fair Value

600298.SS
$5.75Closing price of 20 Nov 2026MEQIRI Score 57 out of 100

The fair value of Angel Yeast under our model is $5.02, the price is 15% above.

The fair value is an estimate from our model, not a price target.

Daily figure as of 20 Nov 2026

Valuation Signal

Fairly valued
Price
$5.80
Fair value
$5.02
Gap to fair value
+16%

Closing price of 19 Nov 2026, used by the daily score.

In our model the price counts as cheap below $3.86 and expensive above $7.16 (uncertainty medium, based on the price swings of the past year).

The two parts of the fair value come to $3.62 (cash-flow model) and $6.41 (industry comparison), and the gap between them shows how uncertain the estimate is.

Calculated with a cost of equity of 7.3%. At 8.3% the fair value would be $4.68, at 6.3% it would be $5.51.

Where the Number Comes From

Earnings × 23.5
$6.41
Earnings per share $0.27
Cash-flow model
$3.62
Fair value (model)
$5.02

Half from the cash-flow model, half from earnings times the sector P/E (23.5).

Ten-year cash-flow model: 3 years from analyst estimates, then extrapolated until growth reaches 2.3% (five-year average government bond yield). Discounted at 7.3% (floor: government bond yield 2.3% plus 5 percentage points, since beta 0.8 times the risk premium would give less).

Calculate with your own assumptions

The Calculation Step by Step

With these figures the cash flow model arrives at $3.62 per share: free cash flow for the next ten years, each year discounted to today at 7.3%, plus the terminal value for the years after. The table explains the calculation; it is not a recommendation.

Calculation as a table
YearFree cash flowSourceDiscount factorPresent value (discounted at 7.3%)
2026−$6.9MEstimate, 8 analysts0.9319−$6.43M
2027$62.15MEstimate, 10 analysts0.8684$53.97M
2028$151.7MEstimate, 9 analysts0.8092$122.76M
2029$165.39Mextrapolated at 9.0%0.7541$124.72M
2030$176.98Mextrapolated at 7.0%0.7027$124.37M
2031$186.89Mextrapolated at 5.6%0.6549$122.39M
2032$195.51Mextrapolated at 4.6%0.6103$119.32M
2033$203.18Mextrapolated at 3.9%0.5687$115.55M
2034$210.17Mextrapolated at 3.4%0.5300$111.38M
2035$216.68Mextrapolated at 3.1%0.4939$107.01M
StepValue
Sum of present values (ten years)$995.04M
Terminal value: cash flow 2035 × (1 + 2.3%) / (7.3% − 2.3%)$4.43B
Present value of terminal value (× 0.4939)$2.19B
Equity value (sum plus present value of terminal value)$3.18B
Shares (diluted)879.50M
Value per share (equity value divided by shares)$3.62
Earnings per share, last twelve months$0.27
× 23.5 (sector P/E)$6.41
Fair value (average of both parts)$5.02

In the years with estimates, the model derives free cash flow from estimated earnings and revenue, because there are no estimates for the cash flow itself. The model uses free cash flow after interest, which belongs to shareholders, discounted at the cost of equity. Net debt is therefore not deducted again.

Data and Required Disclosures

  • ; time horizon around 12 months
  • Rated Neutral since 7 Nov 2026; valuation signal Fairly valued since 7 Nov 2026
  • Price: closing price of 20 Nov 2026
  • Amounts in US dollars at the ECB reference rate of 19 Nov 2026 ($1 = CN¥6.6667)
  • Data from Financial Modeling Prep (FMP) based on the company's reports, latest fiscal year 2025. MEQIRI calculates the score and fair value itself every night.
  • Score and fair value are estimates from a disclosed model. They are not facts and not a price target.
  • Produced by SSM Ventures UG (haftungsbeschränkt), responsible person Sven Brostmeyer, Managing Director, automatically according to the disclosed model.
  • Not investment advice. Losses up to and including a total loss are possible. Personal circumstances are not considered.